Dexcom (DXCM) Long-Term Debt Repayments (2013 - 2023)
Dexcom's (DXCM) quarterly Long-Term Debt Repayments came in at $136.8 million in Q4 2023, up 7947.06% quarter-over-quarter from $1.7 million in Q2 2016.
Analysis
Dexcom (DXCM) Long-Term Debt Repayments (2013 - 2023) Analysis & Trends
Dexcom (DXCM) has reported Long-Term Debt Repayments for 5 consecutive years, with $136.8 million the latest figure, recorded in Q4 2023.
- On a quarterly basis, Long-Term Debt Repayments changed N/A year-over-year to $136.8 million in Q4 2023; TTM through Dec 2024 was $136.8 million, a 0.0% change from a year earlier, with the FY2023 full-year figure at $787.3 million, changed N/A from the prior year.
- Long-Term Debt Repayments was $136.8 million for Q4 2023 at Dexcom, up from $1.7 million in the prior quarter.
- Over five years, Long-Term Debt Repayments peaked at $136.8 million in Q4 2023 and troughed at $136.8 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 1.41 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 17.73 Bn | 17.32 Bn | 1.54 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 136.80 Mn |
| Jun 30, 2016 | 1.70 Mn |
| Mar 31, 2016 | 600,000.00 |
| Dec 31, 2015 | 600,000.00 |
| Sep 30, 2015 | 500,000.00 |
| Jun 30, 2015 | 600,000.00 |
| Mar 31, 2015 | 600,000.00 |
| Dec 31, 2014 | 600,000.00 |
| Sep 30, 2014 | 500,000.00 |
| Jun 30, 2014 | 600,000.00 |
| Mar 31, 2014 | 500,000.00 |
| Dec 31, 2013 | 200,000.00 |